Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank62
3Y CAGR+205.9%
5Y CAGR-5.1%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+205.9%/yr
vs -28.7%/yr prior
5Y CAGR
-5.1%/yr
Recent acceleration
Acceleration
+234.6pp
Accelerating
Percentile
P62
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
202415.83-52.0%
202332.94+4394.1%
20220.73+32.5%
20210.55+392.1%
2020-0.19-100.9%
201920.51+810.3%
20182.25+5.0%
20172.15-63.7%
20165.91-78.2%
201527.11-